Curium’s Investigational New Drug Application Accepted by Center for Drug Evaluation in China Notified -
Pluxee Q1 Fiscal 2026 Revenues - Robust start in the 1st quarter delivering on expectations, All Fiscal 2026 financial objectives confirmed Notified -
GDU Launches UAV-P300, The World’s First Drone with AI-Driven Optical & Electronic Fog Penetration Capabilities Notified -
Ziihera® (zanidatamab-hrii) Combinations Achieve Unprecedented Results in First-Line HER2+ Locally Advanced or Metastatic GEA including more than Two Years Median Overall Survival Benefit Notified -
Insight Timer Launches New Year’s Resolution and Intention-Setting Features with AI Recommendation Engine Notified -
Treasure Global Concludes Alumni Capital Equity Line Facility to Streamline Capital Structure and Focus on Fintech & Digital-Asset Growth Notified -
Synchronoss Showcases Expanded Personal Cloud Platform, Capsyl Momentum, and Previews New Offering at CES 2026 Notified -
Mark Your Calendar: Hong Kong to Host Asia’s 50 Best Restaurants 2026 after Historic Double Win Notified -
Hummingbird Bioscience Announces First Patient Dosed in Phase I Clinical Trial of HMBD-501 in Advanced HER3-Expressing Solid Malignancies Notified -
